NBP-induced ROS has been shown to mediate AKT degradation through the activation of the AKT ubiquitin-proteasome system, mitochondrial E3 ubiquitin protein ligase 1 (MUL1) in head and neck cancer cell lines, and therefore to suppress cancer growth in vitro and in vivo [94]. This evidence concerns the gene MUL1 and cancer.